REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

D & M - Pharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: D & M - Pharma S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

D & M - Pharma S.A. is a company in Ecuador, with a head office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on August 31, 2016. D & M - Pharma S.A. currently employs 5 (2020) people. In its most recent financial highlights, the company reported a net sales revenue increase of 161.09% in 2021. Its’ total assets recorded a growth of 54.46%. The net profit margin of D & M - Pharma S.A. increased by 191.27% in 2021.

Headquarters
Republica del Salvador E9-10
Quito; Pichincha;

Contact Details: Purchase the D & M - Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the D & M - Pharma S.A. report to view the information.
Outstanding Shares:
Purchase the D & M - Pharma S.A. report to view the information.
Registered Capital:
Purchase the D & M - Pharma S.A. report to view the information.
Incorporation Date:
August 31, 2016
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Financial and Administrative Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after D & M - Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
161.09%▲
Total operating revenue
160.87%▲
Operating profit (EBIT)
8.1%▲
Net Profit (Loss) for the Period
5.96%▲
Total assets
54.46%▲
Total equity
-50.59%▼
Operating Profit Margin (ROS)
193.72%▲
Net Profit Margin
191.27%▲
Return on Equity (ROE)
-19.17%▼
Quick Ratio
-1.59%▼
Cash Ratio
-0.32%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo